AI models redefine TIL scoring in breast cancer but face challenges in real-world validation
Tehnologie
By Tarun Sai Lomte Reviewed by Susha Cheriyedath, M.Sc. Nov 21 2024 Researchers explore how AI-driven tumor-infiltrating lymphocyte (TIL) assessments outperform manual methods in precision but stress the need for robust datasets to ensure reliability in clinical practice. Digital image analysis flowchart for classifiers development and utilization. (a) Preprocessing and classifiers training pipeline (KNN10, RT10, NN10, NN20, NN30, NN40 and NN50). (b) Application of TILs models. (c) Analytical
din zilele anterioare